Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-001271-38-BE
EUCTR2006-001271-38-BE
Active, not recruiting
Not Applicable

Intensified pre-operative chemotherapy and radical surgery for HIGH RISK HEPATOBLASTOMA

SIOP0 sites57 target enrollmentJanuary 24, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshigh risk hepatoblastomaMedDRA version: 9.1Level: LLTClassification code 10062001Term: Hepatoblastoma
DrugsParaplatinPlatosinAdriablastina

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
high risk hepatoblastoma
Sponsor
SIOP
Enrollment
57
Status
Active, not recruiting
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
SIOP

Eligibility Criteria

Inclusion Criteria

  • •oHistologically confirmed hepatoblastoma
  • •o\< 18 years of age
  • •oRisk category: high\-risk patient
  • •oWritten informed consent and national/local ethical committee approval
  • •oAbility to comply with requirements for submission of material for central review
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no

Exclusion Criteria

  • •oDiagnosis not confirmed by histology.
  • •oAbnormal renal function defined as GFR \< 60 ml/min/1,73 mP2 Pat diagnosis.
  • •oPatient unable to follow the protocol for any reason.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Intensified pre-operative chemotherapy and radical surgery for HIGH RISK HEPATOBLASTOMASIOPEL 4 - SIOPEL 4Hepatoblastoma
EUCTR2006-001271-38-IEOur Lady's Hospital for Sick Children57
Completed
Phase 1
Preoperative chemoradiation therapy combined with peptide vaccination for T3-pancreatic cancer: prospective phase I/II studyT3(UICC)-pancreatic cancer
JPRN-UMIN000004422Department of Gastroenterological Surgery, Osaka Medical Center for cancer &amp; Cardiovascular Diseases50
Not yet recruiting
Phase 2
Neoadjuvant Chemotherapy followed by Pre-operative Chemoradiation and Consolidation Chemotherapy before Surgery in High Risk Rectal Cancer: Multicentric Phase II Study
2024-517183-31-00Centro Di Riferimento Oncologico Di Aviano93
Recruiting
Not Applicable
Effect of preoperative concurrent chemoradiotherapy in patients with adenocarcinoma of esophagusHealth Condition 1: null- patients with ECOG (0,1,2) - Good performance status
CTRI/2013/09/003981not applicable160
Active, not recruiting
Phase 1
clinical study to evaluate the efficacy of a two drug combination versus a single drug therapy in the treatment of locally advanced rectal cancer.locally advanced rectal cancerMedDRA version: 17.0Level: PTClassification code 10038050Term: Rectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2006-006532-21-DEEORTC1,094